Integra Lifesciences HLD (iart 0.5 08/15/25)

13F holders, Q1 2024 (March 31)
8holders
$1.44avg. 13F price*

At the end of Q1 2024, 8 institutions reported holding Integra Lifesciences HLD (iart 0.5 08/15/25) in their 13F filings. The largest holders were Ofi Invest Asset Management ($12.2M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($4.3M) and Liberty Mutual Group Asset Management Inc. ($1.4M).

Company
Integra Lifesciences HLD (iart 0.5 08/15/25)
CUSIP
457985AM1
Latest filing quarter
Q2 2025

History

Number of 13F holders

02468 Q1 2024: 8Q1 2024Q2 2024: 6Q2 2024Q3 2024: 3Q3 2024Q4 2024: 2Q4 2024Q1 2025: 1Q1 2025Q2 2025: 2Q2 2025

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions0$0
Exits1$3K

Ownership 8 holders

Ofi Invest Asset Management 0.33% Add +91658.3% 6,606,600 $12.2M
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 0.01% No change 4,500,000 $4.3M
Liberty Mutual Group Asset Management Inc. 0.40% Reduce -47.3% 1,475,000 $1.4M
Nomura Holdings Inc. 0.00% Reduce -81.6% 11,361 $403K
Sei Investments Co. 0.00% No change 249,000 $237K
Oppenheimer Asset Management Inc. 0.00% Reduce -50.7% 106,000 $101K
Stephens Inc. 0.00% Add +46.4% 101,000 $96K
Northwestern Mutual Wealth Management Co. 0.00% Reduce -20.0% 12,000 $11K

"% of holder's portfolio" is INTEGRA LIFESCIENCES HLD (IART 0.5 08/15/25)'s weight in each manager's 13F, not the share of Integra Lifesciences HLD (iart 0.5 08/15/25) the manager owns.